跳至主要内容
临床试验/NCT00003736
NCT00003736已完成不适用

Pilot Study: High Risk Breast Cancer Screening Pilot Study

Abramson Cancer Center at Penn Medicine24 个研究点 分布在 2 个国家目标入组 200 人开始时间: 1999年6月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
200
试验地点
24

研究概览

简要总结

RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for breast cancer. Diagnostic procedures such as MRI may improve the ability to detect breast cancer.

PURPOSE: Screening and diagnostic trial to study the effectiveness of MRI scans in women who are at high risk for developing breast cancer.

详细描述

OBJECTIVES:

  • Estimate the diagnostic yield and positive predictive value of breast magnetic resonance imaging (MRI) for the detection of cancer in women who are at greater than 25% lifetime risk for developing breast cancer.
  • Compare the diagnostic yield and positive predictive value of MRI with conventional breast cancer screening (mammography and physical examination) for the detection of breast cancer in women with a greater than 25% lifetime risk of developing breast cancer.

OUTLINE: All patients receive a physical exam within 90 days of initial MRI scan. Patients undergo a two view screening mammogram within 3 months prior to study entry. Patients undergo an MRI with gadolinium contrast at entry. All lesions identified as suspicious on physical examination, mammography, or MRI undergo a core needle or excisional biopsy.

PROJECTED ACCRUAL: A total of 200 patients will be accrued for this study within 2 years.

研究设计

研究类型
Interventional
主要目的
Screening

入排标准

年龄范围
25 Years 至 120 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究者

申办方类型
Other

研究点 (24)

Loading locations...

相似试验